The advertisement promotes Kyprolis (carfilzomib) for injection, highlighting its potential benefits for patients with relapsed refractory multiple myeloma (RRMM) and includes important safety information regarding cardiac toxicities.
Creative Information
| CID: | a8ac3a8b-a7de-4fcf-8b7b-a18e02c48a3e |
| CRID: | 89_219259 |
| Domain: | kyprolis.com |
| Seat: | DInt |
| Size: | 300x600 |
| Bid: | $1.71 |
| Timestamp: | 10/31/2025, 6:44:59 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 10/31/2025, 8:09:09 PM | 6.15s | |
| adomain_analysis | success | 10/31/2025, 9:28:07 PM | 3.11s | |
| adomain_capture | success | 10/31/2025, 9:28:03 PM | 31.94s | |
| ad_render | success | 10/31/2025, 8:09:03 PM | 35.58s | |
| brand_mapping | success | 10/31/2025, 8:09:04 PM | 0.92s | |
Analysis Results
Ad Format: banner
Brands: Kyprolis
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 300x600 | ||||||||||||||||||||||
| Data Transferred: | 1382.13 KB | ||||||||||||||||||||||
| Render Time: | 10.16 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1382.22 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives


